Plan to resume MAGNITUDE-2 patient enrollment and dosing FDA engagement ongoing regarding clinical hold on MAGNITUDE Phase 3 ...

One of the most inherent risks is the risk of damaging healthy genes. This rather brutal issue is step one of risk management. It also means large sequences of amino acids that must be checked, ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.65, marking a -1.57% move from the previous day. This move lagged the S&P 500's daily gain of 0.5%. On the other hand, the ...

What if a cup of coffee could help treat cancer? Researchers at the Texas A&M Health Institute of Biosciences and Technology ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

Keanu Reeves was revealed to be the secret donor behind a $500 million trust that has quietly renovated apartment complexes.

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

Cathie Wood predicts stock market golden age through 2026 with 6-8% GDP growth. ARK Innovation ETF returned 35% in 2025 vs ...

Stem cell IVF could enable same-sex couples and single parents to have genetically related children. It’s time to think ...

Keeping up with new medical technology is a big deal for anyone working in healthcare. As we get into 2026, it’s pretty clear ...

ARK Invest CEO Cathie Wood, known for big bets on disruptive technologies, said she see strong gains for U.S. equities in the ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...